# Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients

> **NCT00350662** · PHASE3 · COMPLETED · sponsor: **Lipomed** · enrollment: 95 (actual)

## Conditions studied

- Hemochromatosis

## Interventions

- **DRUG:** Deferiprone (L1)
- **DRUG:** Desferrioxamine

## Key facts

- **NCT ID:** NCT00350662
- **Lead sponsor:** Lipomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2012-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00350662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00350662, "Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00350662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*